Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neumoterol 400 vs Symbicort Forte in Asthma
NCT02233803Phase 4Completed
- Sponsor
- GSK
- Start
- Nov 2014
- Primary completion
- Dec 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of budesonide + formoterol in asthma, sponsored by GSK. Started Nov 2014; status: completed.
02
Drugs
budesonide + formoterol
03
Conditions
asthma
Beyond the preview
Go deeper on NCT02233803.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02233803.